Phase II combination of pemetrexed and oxaliplatin in patients with recurrent non-small cell lung cancer after failure to platinum based adjuvant chemotherapy
Phase of Trial: Phase II
Latest Information Update: 27 Mar 2017
At a glance
- Drugs Oxaliplatin (Primary) ; Pemetrexed (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 14 Mar 2008 New trial record.